(Reuters) - The European Medicines Agency said on Wednesday there was no evidence so far linking AstraZeneca's COVID-19 vaccine to illnesses in two people who received it in Austria, one of whom died 10 days after being inoculated.
The Austrian national health authority suspended the use of a batch of the vaccine after a person who was vaccinated was diagnosed with multiple thrombosis and later died, and another was hospitalised with pulmonary embolism.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!